American Academy of Neurology to Honor Jon Kleen, MD, PhD Jon Kleen is named the 2023 Dreifuss-Penry Epilepsy Award recipient by the American Academy of Neurology (AAN). He is honored for his contributions to epilepsy treatment.
First Molecular Images of Olfaction Open Door to Creating Novel Smells In a first, UCSF scientists created a molecular-level, 3D picture of how an odor molecule activates a human odorant receptor.
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
20-Year Study Shows Advances in Care Have Improved Outcomes for Newborns with Congenital Heart Disease (CHD) Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.
UCSF-Led Study Shows Benzos, Antidepressants, Ambien May Impact CognitionSleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.
On the operating table and inside the lab of a rising star in cancer neurosurgery.On the operating table and inside the lab of a rising star in cancer neurosurgery.
Could psychedelics become mainstream medicines?Could psychedelics become mainstream medicines?
UCSF-Led Study Shows Extensive Resection Results in Longer Survival for Glioma PatientsResecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
Lecanemab, Donanemab, Drug-Free Strategies Emerge as New Weapons Against DementiaUCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
